Vanguard Group Inc G1 Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,081,573 shares of GTHX stock, worth $4.75 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,081,573
Previous 1,981,673
5.04%
Holding current value
$4.75 Million
Previous $6.04 Million
48.78%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding GTHX
# of Institutions
95Shares Held
14.7MCall Options Held
631KPut Options Held
347K-
Susquehanna International Group, LLP Bala Cynwyd, PA951KShares$2.17 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny904KShares$2.06 Million0.01% of portfolio
-
Raymond James & Associates St Petersburg, FL803KShares$1.83 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY785KShares$1.79 Million0.0% of portfolio
-
Black Rock Inc. New York, NY672KShares$1.53 Million0.0% of portfolio
About G1 Therapeutics, Inc.
- Ticker GTHX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,746,800
- Market Cap $97.5M
- Description
- G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...